Citizens Financial Group Inc Astrazeneca PLC Transaction History

Citizens Financial Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$53.07 - $61.1 $29,984 - $34,521	-565 Closed	0 $0
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $7,982 - $9,486	-188 Reduced 24.97%	565 $28,000
Q3 2019 Nov 01, 2019	SELL	$40.12 - $45.47 $320 - $363	-8 Reduced 1.05%	753 $33,000
Q2 2019 Aug 09, 2019	BUY	$37.28 - $41.68 $7,083 - $7,919	190 Added 33.27%	761 $31,000
Q1 2019 May 09, 2019	BUY	$35.49 - $43.02 $20,264 - $24,564	571 New	571 $23,000
Q3 2017 Nov 13, 2017	SELL	$28.96 - $34.0 $2,809 - $3,298	-97 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	97	97 $3,000

1,358

512M

6.08M

4.44M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

Stay updated on Citizens Financial Group Inc with notifications on news.